E-Library

Accessing Diabetes Medications: A Pan-Canadian Analysis of Patient Experiences The Conference Board of Canada, 32 pages, November 14, 2019 Report by Cameron MacLaine, Junyi Feng, Monika Slovinec D’Angelo, Nigel Russell

Accessing Diabetes Medications: A Pan-Canadian Analysis of Patient Experiences

The Conference Board of Canada, 32 pages, November 14, 2019
Report by Cameron MacLaine, Junyi Feng, Monika Slovinec D’Angelo, Nigel Russell

1 2 3 4 5	0 reviews

(You must be signed in and entitled to rate this report)

This research discusses the issues patients face when managing, treating, and controlling their diabetes over the long term. It also points to the need for a more integrated Canadian health system. Document Highlights Medicines are a key component of a range of therapeutic interventions that Canadians use to prevent, manage, and cure health conditions. Patients living with diabetes depend on access to evidence-based, individualized treatments to maintain and improve their health outcomes, reduce complications, and increase overall quality of life and lifespan. As part of a broader research agenda exploring options for universal pharmacare in Canada, The Conference Board of Canada completed research on how patients with diabetes access necessary medications. Accessing Diabetes Medications: A Pan-Canadian Analysis of Patient Experiences discusses the issues patients face when managing, treating, and controlling their health conditions over the long term. It also points to the need for a more integrated health system focused on outcomes that are meaningful to patients. To this end, it is essential that these outcomes be measured and assessed in a standardized way, and used as the basis for continuous quality improvement efforts. Table of Contents Key findings Introduction Results Summary of findings and discussion Conclusion Appendix A: Methodology and analysis Appendix B: Active ingredients in medications to treat diabetes Appendix C: Additional data Appendix D: Bibliography

This research discusses the issues patients face when managing, treating, and controlling their diabetes over the long term. It also points to the need for a more integrated Canadian health system.

Document Highlights

Medicines are a key component of a range of therapeutic interventions that Canadians use to prevent, manage, and cure health conditions. Patients living with diabetes depend on access to evidence-based, individualized treatments to maintain and improve their health outcomes, reduce complications, and increase overall quality of life and lifespan.

As part of a broader research agenda exploring options for universal pharmacare in Canada, The Conference Board of Canada completed research on how patients with diabetes access necessary medications. Accessing Diabetes Medications: A Pan-Canadian Analysis of Patient Experiences discusses the issues patients face when managing, treating, and controlling their health conditions over the long term. It also points to the need for a more integrated health system focused on outcomes that are meaningful to patients. To this end, it is essential that these outcomes be measured and assessed in a standardized way, and used as the basis for continuous quality improvement efforts.